David Riley, MD
Dr. Riley is the Editor-in-Chief of Alternative Therapies in Health and Medicine, a peer reviewed medical journal indexed in the National Library of Medicine. He is the founder of the Integrative Medicine Institute which is conducting health services research on effectiveness, safety, patient satisfaction, and costs when complementary and alternative therapies are integrated with conventional medicine.
Dr. Riley's primary interest in medicine is conducting health services research and improving patient care through the evidence-based integration of conventional and alternative therapies. He attended Georgetown and the University of Utah Medical Schools and graduated from the University of Utah School of Medicine in 1983. His undergraduate studies were at the University of North Carolina, where he graduated in 1976 with a BA in music and honors in psychology. He is currently a Clinical Associate Professor at the University of New Mexico Medical School, board certified in Internal Medicine, a certified yoga instructor and is studying the Biodynamic approach to osteopathy. In 1993 Dr. Riley completed a three-year training program in homeopathy at the Hahnemann College of Homeopathy in Albany, California.
He has conducted many clinical trials. He was the principle investigator on the International Integrative Primary Care Outcome Studies I and II. This multi-center outcomes study evaluated patient care outcomes when complementary and alternative therapies were integrated in primary care. He has been involved in the development and implementation of data collection networks collecting practitioner and patient outcome and satisfaction data. Southwest Health Options, co-founded by Dr. Riley, was an independent practice association (IPA) managing the delivery of complementary and alternative medicine (CAM) for insured patients in Santa Fe, New Mexico. As the medical director of Southwest Health Options, Dr. Riley directed the peer review and utilization management, and developed credentialing standards acceptable to both the insurance industry and the CAM community.
Dr. Riley is a board member of the Homeopathic Pharmacopoeia of the United States (HPCUS), a technical advisory board to the FDA for regulatory issues concerning homeopathy. Dr. Riley lectures and consults internationally on a range of healthcare issues with a focus on research, education, and regulatory affairs.